Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
Clinical trial NCT01532336 · COMPLETED
Trial details
- NCT number
- NCT01532336
- Sponsor
- NovaBay Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2014-05-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.